Delivering reliable stability data for global approvals.
Sciom provides comprehensive ICH stability testing and storage services to accurately determine shelf-life, storage conditions, and long-term product performance for finished pharmaceutical products. Our ICH-compliant stability studies include real-time, intermediate, and accelerated testing across all dosage forms, supported by flexible protocol design tailored to your regulatory timelines and global submission requirements.
ICH-aligned, accurate, and compliant stability studies.
Sciom delivers ICH-compliant stability testing services using GMP-certified stability chambers and continuous environmental monitoring to ensure accurate, reliable, and audit-ready data. Our experts design custom stability protocols aligned with your product development stage and global regulatory requirements, enabling seamless submissions and faster approvals.
Stability Testing Capabilities
Precision from protocol to report.
Sciom develops ICH-compliant stability protocols defining time points, storage conditions, test intervals, and acceptance criteria based on product type, development phase, and regional regulatory requirements.
Stability batches are carefully prepared, labelled, and assigned to GMP stability chambers, with pull-point schedules aligned to the approved protocol.
Our GMP-certified stability chambers maintain precise conditions (2–8°C, 25°C/60%RH, 30°C/75%RH, 40°C/75%RH) with 24/7 temperature and humidity monitoring and routine QA oversight.
Samples are tested at predefined intervals (0, 3, 6, 9, 12, 18, 24, 36 months) using validated stability-indicating methods for assay, impurities, dissolution, and physical attributes.
All results are evaluated against specifications and trended over time, with ICH Q1E statistical analysis used to determine degradation patterns and shelf-life projections.
Periodic stability reports (quarterly/annual) provide insights into trends, deviations, and excursions, while OOS results trigger immediate investigation and regulatory notification.
Final reports include statistical shelf-life determination, storage recommendations, and complete CTD Module 3 documentation for regulatory submissions.
Post-approval, Sciom supports ongoing stability studies through commitment batches and annual reporting to ensure continued compliance and lifecycle management.
Aligned with ICH guidelines for global compliance.
Sciom ensures ICH-compliant stability testing that generates accurate, reliable shelf-life data aligned with global regulatory guidelines, supporting successful submissions and ongoing compliance throughout the product lifecycle.
Designs ICH Q1-aligned stability protocols tailored to product type, development phase, and regional regulatory requirements
Executes real-time, accelerated, intermediate, and stress stability studies at defined pull points
Maintains GMP-certified stability chambers with continuous 21 CFR Part 11-compliant environmental monitoring
Performs stability-indicating testing for assay, impurities, dissolution, and physical characteristics
Applies ICH Q1D bracketing and matrixing along with ICH Q1E statistical evaluation for accurate shelf-life determination
Delivers interim stability reports, trend analysis, and final CTD Module 3 documentation for regulatory submissions
Supports post-approval commitment batches and in-use stability programs
Ensures ALCOA+ data integrity, enabling inspection readiness and robust audit defense
Precision backed by science.
Real-time (25°C/60%RH, 30°C/75%RH), accelerated (40°C/75%RH), and intermediate studies across all dosage forms with continuous environmental validation.
Bracketing and matrixing protocols reduce testing burden by 30–50% while maintaining full regulatory acceptability for multiple strengths and pack types.
Advanced trend analysis with confidence intervals, extrapolation justification, and shelf-life decision trees per ICH statistical requirements.
ICH-aligned shelf-life determination through real-time data trending, plus inverted container and in-use stability for multidose products, ensuring full commercial performance claims.
MHRA/EMA/FDA-aligned stability packages with region-specific protocols, bridging studies, and hybrid applications – seamless worldwide commercialization from one trusted partner.
Proven expertise, reliable results, global compliance.
Sciom delivers MHRA-approved stability testing services with expert QP oversight, ensuring first-time regulatory acceptance and faster market access for your pharmaceutical products.
Full GMP-compliant stability testing supporting approvals across EMA, MHRA, and global regulatory authorities.
Advanced ICH Q1D bracketing and matrixing reduce testing volumes by 30–50% without compromising quality or compliance.
Customized study designs aligned with your dosage form, storage conditions, and regional submission requirements.
Continuous environmental monitoring and ALCOA+ data integrity ensure audit readiness and prevent deviations or regulatory findings.
Everything you need. One trusted partner.
Stay informed with expert commentary on pharmacovigilance services, regulatory consulting services, analytical science and audit compliance services across the pharmaceutical industry.